Infusive Compounding Global Equities ETF
JOYY
JOYY was delisted on the 10th of June, 2022.
4 hedge funds and large institutions have $7.92M invested in Infusive Compounding Global Equities ETF in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
27% more capital invested
Capital invested by funds: $6.22M → $7.92M (+$1.7M)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.47M |
| 2 |
IAM
Infusive Asset Management
New York
|
+$113K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$73.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$47.8K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$23K |
JOYY Hedge Fund Activity: Q1 2022 in Review
4 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Infusive Compounding Global Equities ETF (JOYY) for Q1 2022, worth a combined $7.92M — up 27% from $6.22M a quarter earlier.
Fund positioning in JOYY was balanced in Q1 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $2.47M. The largest seller was UBS Group, cutting an estimated $47.8K.
- 4 institutional investors held Infusive Compounding Global Equities ETF (JOYY) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $7.92M of Infusive Compounding Global Equities ETF stock for Q1 2022, up 27% quarter-over-quarter.
- 1 fund opened new Infusive Compounding Global Equities ETF positions in Q1 2022 and 1 closed out, a net change of 0 holders.
- The largest Infusive Compounding Global Equities ETF buyer in Q1 2022 was Jane Street, an estimated $2.47M added.
- The largest Infusive Compounding Global Equities ETF seller in Q1 2022 was UBS Group, an estimated $47.8K sold.
Based on aggregated 13F filings for Q1 2022.